Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRVL

Prevail Therapeutics (PRVL) Stock Price, News & Analysis

Prevail Therapeutics logo

About Prevail Therapeutics Stock (NASDAQ:PRVL)

Advanced Chart

Key Stats

Today's Range
$23.00
$23.00
50-Day Range
$22.91
$23.20
52-Week Range
$9.02
$23.35
Volume
N/A
Average Volume
955,800 shs
Market Capitalization
$787.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRVL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prevail Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PRVL Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

PRVL Stock Analysis - Frequently Asked Questions

Prevail Therapeutics Inc. (NASDAQ:PRVL) announced its quarterly earnings results on Friday, November, 13th. The company reported ($0.55) EPS for the quarter, beating analysts' consensus estimates of ($0.64) by $0.09.

Prevail Therapeutics (PRVL) raised $126 million in an initial public offering on Thursday, June 20th 2019. The company issued 7,400,000 shares at $16.00-$18.00 per share. Morgan Stanley, BofA Merrill Lynch and Cowen and Company served as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Prevail Therapeutics investors own include NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Editas Medicine (EDIT), Alector (ALEC), Advanced Micro Devices (AMD), Atreca (BCEL) and Homology Medicines (FIXX).

Company Calendar

Last Earnings
11/13/2020
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:PRVL
CIK
N/A
Fax
N/A
Employees
66
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63.19 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-55.57%
Return on Assets
-48.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.56
Quick Ratio
7.56

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.85 per share
Price / Book
4.74

Miscellaneous

Outstanding Shares
34,246,000
Free Float
N/A
Market Cap
$787.66 million
Optionable
Not Optionable
Beta
1.59
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:PRVL) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners